N@N

CORRECTINGand REPLACINGTargacept Announces Participation in Upcoming Conferences

^{Published on 2010-05-18 07:40:15 - Market Wire}
 

WINSTON-SALEM, N.C.--([ BUSINESS WIRE ])--First bullet, date of Citi 2010 Global Health Care Conference should read: Wednesday, May 26, 2010 (sted: Wednesday, May 25, 2010).

The corrected release reads:

TARGACEPT ANNOUNCES PARTICIPATION IN UPCOMING CONFERENCES

Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics (TM), today announced that Alan A. Musso, Senior Vice President, Finance and Administration and Chief Financial Officer, is scheduled to present at the following conferences:

• Citi 2010 Global Health Care Conference at the Hilton New York Hotel in New York on Wednesday, May 26, 2010 at 2:00 p.m. Eastern Daylight Time; and
• 9^th Annual Needham Healthcare Conference at the New York Palace Hotel in New York on Wednesday, June 9, 2010 at 9:20 a.m. Eastern Daylight Time.

Each presentation will be audio webcast and accessible from the Investor Relations page of Targacepta™s website, [ www.targacept.com ]. To ensure a timely connection to either webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of each audio presentation will also be available for replay on the Investor Calendar section of the Investor Relations page of Targacepta™s website for at least two weeks following the corresponding event.

About Targacept

Targacept is a clinical-stage biopharmaceutical company with a vision of building health and restoring independence for patients. Targacept has leveraged its leadership position in NNR research to build a diverse pipeline of NNR Therapeutics(TM) in development to treat an array of central nervous system diseases and disorders, including major depressive disorder, attention deficit/hyperactivity disorder, Alzheimera™s disease and cognitive dysfunction in schizophrenia. In addition, Targacept has alliances with the global pharmaceutical companies AstraZeneca and GlaxoSmithKline. Targacepta™s news releases are available on its website at [ www.targacept.com ].